Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning

被引:223
作者
Fändrich, F
Lin, XB
Chai, GX
Schulze, M
Ganten, D
Bader, M
Holle, J
Huang, DS
Parwaresch, R
Zavazava, N
Binas, B
机构
[1] Univ Kiel, Dept Gen Surg & Thorac Surg, D-24105 Kiel, Germany
[2] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany
[3] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA
[4] Univ Kiel, Inst Hematopathol, D-24105 Kiel, Germany
[5] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA
[6] VA Med Ctr, Iowa City, IA USA
[7] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA
关键词
D O I
10.1038/nm0202-171
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hematopoietic stem cells have been successfully employed for tolerance induction in a variety of rodent and large animal studies. However, clinical transplantation of fully allogeneic bone marrow or blood-borne stem cells is still associated with major obstacles, such as graft-versus-host disease or cytoreductive conditioning-related toxicity. Here we show that when rat embryonic stem cell-like cells of WKY origin are injected intraportally into fully MHC-mismatched DA rats, they engraft permanently (>150 days) without supplementary host conditioning. This deviation of a potentially alloreactive immune response sets the basis for long-term graft acceptance of second-set transplanted WKY cardiac allografts. Graft survival was strictly correlated with a state of mixed chimerism, which required functional thymic host competence. Our results provide a rationale for using preimplantation-stage stem cells as vehicles in gene therapy and for the induction of long-term graft acceptance.
引用
收藏
页码:171 / 178
页数:8
相关论文
共 39 条
  • [1] Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts
    Allison, J
    Georgiou, HM
    Strasser, A
    Vaux, DL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) : 3943 - 3947
  • [2] Bianchi DW, 1998, J PERINAT MED, V26, P175
  • [3] IMMUNOENZYMATIC LABELING OF MONOCLONAL-ANTIBODIES USING IMMUNE-COMPLEXES OF ALKALINE-PHOSPHATASE AND MONOCLONAL ANTI-ALKALINE PHOSPHATASE (APAAP COMPLEXES)
    CORDELL, JL
    FALINI, B
    ERBER, WN
    GHOSH, AK
    ABDULAZIZ, Z
    MACDONALD, S
    PULFORD, KAF
    STEIN, H
    MASON, DY
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1984, 32 (02) : 219 - 229
  • [4] Different in vivo tolerogenicity of MHC class I peptides
    Fändrich, F
    Zhu, XF
    Schröder, J
    Dresske, B
    Henne-Bruns, D
    Oswald, H
    Zavazava, N
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 65 (01) : 16 - 27
  • [5] FERRARA JL, 1989, BIOL BLOOD MARROW TR, V5, P347
  • [6] H-2 ANTIGENS OF THYMUS DETERMINE LYMPHOCYTE SPECIFICITY
    FINK, PJ
    BEVAN, MJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 148 (03) : 766 - 775
  • [7] Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover
    French, LE
    Hahne, M
    Viard, I
    Radlgruber, G
    Zanone, R
    Becker, K
    Muller, C
    Tschopp, J
    [J]. JOURNAL OF CELL BIOLOGY, 1996, 133 (02) : 335 - 343
  • [8] George JF, 1999, INT J MOL MED, V4, P475
  • [9] An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow
    George, JF
    Sweeney, SD
    Kirklin, JK
    Simpson, EM
    Goldstein, DR
    Thomas, JM
    [J]. NATURE MEDICINE, 1998, 4 (03) : 333 - 335
  • [10] FAS LIGAND-INDUCED APOPTOSIS AS A MECHANISM OF IMMUNE PRIVILEGE
    GRIFFITH, TS
    BRUNNER, T
    FLETCHER, SM
    GREEN, DR
    FERGUSON, TA
    [J]. SCIENCE, 1995, 270 (5239) : 1189 - 1192